In recent years, considerable progress has been made in the analysis of hematopoietic
chimerism after allogeneic stem cell transplantation (SCT). The introduction of serial and …

Allogeneic stem cell transplantation (allo-SCT) is the treatment of choice for many patients
with hematological malignancies, as well as some non-malignant hematological disorders …

Posttransplant leukemia detection before overt relapse is key to the success of
immunotherapeutic interventions, as they are more efficient when leukemia burden is low …

Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is performed
mainly in patients with high-risk or advanced hematologic malignancies and congenital or …

The utility of routine chimerism analysis as a prognostic indicator of subsequent outcomes
after allogeneic hematopoietic cell transplantation (HCT) with myeloablative conditioning …

Chimerism dynamics in bone marrow, peripheral blood (PB), and T lymphocytes (TL) has
been associated with the development of various complications after allogeneic stem-cell …

Pre-emptive DLI (pDLI) is an effective strategy in lowering the risk of relapse without
significantly increasing the risk of graft-versus-host disease (GVHD) in the case of T cell …

Molecular monitoring of hematopoietic chimerism has become a routine diagnostic
approach in patients after allogeneic stem cell transplantation. Chimerism testing permits the …

This prospective study evaluated the kinetics of lymphoid (CD3) engraftment in 110 patients
with acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) after allogeneic …

23 patients with ALL (n= 9) and AML (n= 14) underwent nonmyeloablative stem cell
transplantation (NST) from an HLA-identical donor after conditioning with fludarabine (180 …